rss Posted January 22, 2019 Report Share Posted January 22, 2019 Clinical and erythema-Directed imaging evaluation of Papulo-Pustular rosacea with topical ivermectin: A 32 weeks duration study. J Dermatolog Treat. 2019 Jan 20;:1-15 Authors: Dall'Oglio F, Lacarrubba F, Luca M, Boscaglia S, Micali G Abstract BACKGROUND: Ivermectin (IVM) 1% cream represents an emerging therapy for papulo-pustular rosacea (PPR) and erythema-directed photography is a useful tool for evaluation of patient's erythema. OBJECTIVE: The aim of our study was to assess the efficacy of IVM in PPR in achieving clear status at 8 weeks and, if unresponsive up to 20 weeks followed by respectively 24 and 12 weeks follow-up, using clinical/instrumental evaluation. METHODS: Twenty patients with PPR were instructed to apply IVM for 8 weeks. At week 8, in case of complete response the therapy was stopped and a follow-up period up to 24 weeks was carried out, whereas in case of improvement the treatment was extended for additional 12 weeks followed by a 12 weeks follow-up. Instrumental evaluation was performed by erythema-directed digital photography (VISIA-CRTM- RBXTM). RESULTS: At week 8, complete response was observed in 31.6% of cases along with a significant decrease of erythema degree. During treatment extension, additional improvement in terms of complete response, respectively at 12 (42%), 16 (47%) and 20 (58%) weeks, and reduction of erythema degree was observed. CONCLUSIONS: IVM is a valuable therapeutic option in mild/moderate PPR. Erythema-directed digital photography enhances erythema changes visualization compared to clinical observation alone. PMID: 30663445 [PubMed - as supplied by publisher] {url} = URL to article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now